Safety and Efficacy Study of MGuard Stent After a Heart Attack

PHASE4CompletedINTERVENTIONAL
Enrollment

433

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Myocardial Infarction
Interventions
DEVICE

MGuard

MGuard™ stent comprises a balloon-expandable, thin-strut stainless steel (316L) bare metal stent platform (strut width 100 µm) with mesh sleeve fibers of polyethyleneterephtalate (fiber width of 20 µm) attached to its outer surface. These fibers act like a net (aperture size 150 x 180 µm) preventing distal embolization of the plaque debris/thrombus placed between the vessel wall and the stent.

DEVICE

Control BMS or DES

Control BMS or DES

Trial Locations (7)

Unknown

Klinika Kardiologii Inwazyjnej Uniwersytetu Medycznego w Białymstoku, Bialystok

Gilghsin: John Paul II Hospital, Krakow

Szpital Uniwersytecki w Krakowie, Krakow

Oddział Kardiologii Inwazyjnej, Nowy Targ

Centrum Kardiologii Inwazyjnej GVM Carint, Oświęcim

Centralny Szpital Kliniczny MSWiA w Warszawie, Warsaw

Milpark Hospital, Johannesburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InspireMD

INDUSTRY

NCT01368471 - Safety and Efficacy Study of MGuard Stent After a Heart Attack | Biotech Hunter | Biotech Hunter